Cargando…
Loss of AID exacerbates the malignant progression of CLL
Activation-induced cytidine deaminase (AID) has been implicated as both a positive and a negative factor in the progression of B cell chronic lymphocytic leukemia (CLL), but the role that it plays in the development and progression of this disease is still unclear. We generated an AID knockout CLL m...
Autores principales: | Lee, Avery C., Pingali, Sai Ravi, Pinilla-Ibarz, Javier A., Atchison, Michael L., Koumenis, Constantinos, Argon, Yair, Thomas-Tikhonenko, Andrei, De Trez, Carl, Hu, Chih-Chi Andrew, Tang, Chih-Hang Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522595/ https://www.ncbi.nlm.nih.gov/pubmed/36042317 http://dx.doi.org/10.1038/s41375-022-01663-5 |
Ejemplares similares
-
STING regulates BCR signaling in normal and malignant B cells
por: Tang, Chih-Hang Anthony, et al.
Publicado: (2020) -
CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum
por: Bagashev, Asen, et al.
Publicado: (2018) -
Melanoma and CLL co-occurrence and survival: role of KC history
por: Zhao, Yayi, et al.
Publicado: (2023) -
CLL and COVID-19: light at the end of the tunnel?
por: Scarfò, Lydia, et al.
Publicado: (2022) -
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model
por: Maharaj, Kamira, et al.
Publicado: (2020)